Identification of Poly-N-Acetyllactosamine-Carrying Glycoproteins from HL-60 Human Promyelocytic Leukemia Cells Using a Site-Specific Glycome Analysis Method, Glyco-RIDGE. 2018

Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
Glycoscience & Glycotechnology Research Group, Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science & Technology, Tsukuba, Ibaraki, 305-8568, Japan.

To elucidate the relationship between the protein function and the diversity and heterogeneity of glycans conjugated to the protein, glycosylation sites, glycan variation, and glycan proportions at each site of the glycoprotein must be analyzed. Glycopeptide-based structural analysis technology using mass spectrometry has been developed; however, complicated analyses of complex spectra obtained by multistage fragmentation are necessary, and sensitivity and throughput of the analyses are low. Therefore, we developed a liquid chromatography/mass spectrometry (MS)-based glycopeptide analysis method to reveal the site-specific glycome (Glycan heterogeneity-based Relational IDentification of Glycopeptide signals on Elution profile, Glyco-RIDGE). This method used accurate masses and retention times of glycopeptides, without requiring MS2, and could be applied to complex mixtures. To increase the number of identified peptide, fractionation of sample glycopeptides for reduction of sample complexity is required. Therefore, in this study, glycopeptides were fractionated into four fractions by hydrophilic interaction chromatography, and each fraction was analyzed using the Glyco-RIDGE method. As a result, many glycopeptides having long glycans were enriched in the highest hydrophilic fraction. Based on the monosaccharide composition, these glycans were thought to be poly-N-acetyllactosamine (polylactosamine [pLN]), and 31 pLN-carrier proteins were identified in HL-60 cells. Gene ontology enrichment analysis revealed that pLN carriers included many molecules related to signal transduction, receptors, and cell adhesion. Thus, these findings provided important insights into the analysis of the glycoproteome using our novel Glyco-RIDGE method. Graphical Abstract ᅟ.

UI MeSH Term Description Entries
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015473 Leukemia, Promyelocytic, Acute An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. Leukemia, Myeloid, Acute, M3,Leukemia, Progranulocytic,Myeloid Leukemia, Acute, M3,Progranulocytic Leukemia,Promyelocytic Leukemia, Acute,AML M3,Acute Promyelocytic Leukemia,Leukemia, Acute Promyelocytic,M3 ANLL,ANLL, M3,Acute Promyelocytic Leukemias
D057927 Hydrophobic and Hydrophilic Interactions The thermodynamic interaction between a substance and WATER. Hydrophilic Interactions,Hydrophilic and Hydrophobic Interactions,Hydrophilicity,Hydrophobic Interactions,Hydrophobicity,Hydrophilic Interaction,Hydrophilicities,Hydrophobic Interaction,Hydrophobicities,Interaction, Hydrophilic,Interaction, Hydrophobic,Interactions, Hydrophilic,Interactions, Hydrophobic
D018922 HL-60 Cells A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8) HL60 Cells,Cell, HL60,Cells, HL60,HL 60 Cells,HL-60 Cell,HL60 Cell
D019032 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. Laser Desorption-Ionization Mass Spectrometry, Matrix-Assisted,MALD-MS,MALDI,Mass Spectrometry, Matrix-Assisted Laser Desorption-Ionization,Mass Spectroscopy, Matrix-Assisted Laser Desorption-Ionization,Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry,Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization,MALDI-MS,MS-MALD,SELDI-TOF-MS,Surface Enhanced Laser Desorption Ionization Mass Spectrometry,Laser Desorption Ionization Mass Spectrometry, Matrix Assisted,MALDI MS,Mass Spectrometry, Matrix Assisted Laser Desorption Ionization,Mass Spectroscopy, Matrix Assisted Laser Desorption Ionization,Matrix Assisted Laser Desorption Ionization Mass Spectrometry

Related Publications

Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
February 2003, Current protein & peptide science,
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
January 1997, Advances in experimental medicine and biology,
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
January 1988, Biomedica biochimica acta,
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
January 1987, Journal of immunology (Baltimore, Md. : 1950),
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
November 1990, The Journal of biological chemistry,
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
October 1984, The Journal of pharmacology and experimental therapeutics,
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
September 2009, Toxicological research,
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
October 1980, Cancer letters,
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
November 2001, Chemical research in toxicology,
Akira Togayachi, and Azusa Tomioka, and Mika Fujita, and Masako Sukegawa, and Erika Noro, and Daisuke Takakura, and Michiyo Miyazaki, and Toshihide Shikanai, and Hisashi Narimatsu, and Hiroyuki Kaji
May 1986, Blood,
Copied contents to your clipboard!